TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.980
+0.010 (0.51%)
At close: Oct 8, 2025, 4:00 PM EDT
1.990
+0.010 (0.51%)
After-hours: Oct 8, 2025, 7:40 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $112.36 million as of October 8, 2025. Its market cap has decreased by -59.21% in one year.
Market Cap
112.36M
Enterprise Value
-8.98M
1-Year Change
-59.21%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $112.36M, a decrease of -68.71%. That is a compound annual growth rate of -24.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 112.36M | -34.59% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.82B |
| Johnson & Johnson | 453.97B |
| AbbVie | 406.04B |
| UnitedHealth Group | 326.71B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.72B |